Skip to main content

Table 1 Patients' characteristics

From: Salvage radiotherapy for biochemical relapse after complete PSA response following radical prostatectomy: outcome and prognostic factors for patients who have never received hormonal therapy

  

N

%

Clinical Stage:

 

T1c

6

14

 

T2a

3

7

 

T2b

2

4.7

 

T2c

1

2.3

 

Unknown

31

72

Preoperative PSA:

 

<10 ng/ml

24

55.80

 

10–20 ng/ml

9

21.0

 

>20

8

18.60

 

Unknown

2

4.6

Preoperative Gleason Score:

 

<6

10

23.2

 

.6

12

27.9

 

>6

6

13.9

 

unknown

15

34.9

Pathological Stage:

 

pT2a

11

25.6

 

pT2b

3

7

 

pT2c

7

16.3

 

pT3a

21

48.8

 

pT3b

1

2.3

Postoperative Gleason Score:

 

<6

7

16.3

 

.6

13

30.2

 

>6

23

53.5

Surgical margins:

 

Compromised

23

53.5

 

Clear

20

46.5

PNI:

 

Yes

30

69.7

 

No

6

14

 

Unknown

7

16.3

LVI:

 

Yes

6

14

 

No

25

58

 

Unknown

12

28

BVI:

 

Yes

3

7

 

No

27

62.8

 

Unknown

13

30.2

PIN:

 

Yes

11

25.6

 

No

7

16.3

 

Unknown

25

58

Total:

 

43

100

  1. PNI, perineural invasion; LVI, Limphovascular space invasion,
  2. BVI, blood vascular space invasion; PIN, prostatic intraepithelial neoplasia